CRPC

Clinical trials for CRPC explained in plain language.

Never miss a new study

Get alerted when new CRPC trials appear

Sign up with your email to follow new studies for CRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug JAB-8263 tested in advanced cancers – hope for hard-to-treat tumors

Disease control Recruiting now

This early-stage trial tests a new drug called JAB-8263 in adults with advanced solid tumors (like lung, ovarian, or esophageal cancer) or blood cancers (like leukemia). The goal is to find a safe dose and see if it can shrink tumors. About 152 people whose cancer has worsened af…

Matched conditions: CRPC

Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control

Last updated May 01, 2026 15:58 UTC

CRPC

Get alerted when new CRPC trials appear

New drug JAB-8263 tested in advanced cancers – hope for hard-to-treat tumors